NATIONAL HEALTHCARE CORP (NHC) Stock Fundamental Analysis
USA - NYSEARCA:NHC - US6359061008 - Common Stock
123.43 USD
+1.48 (+1.21%)
123.43 USD
0 (0%)
Taking everything into account, NHC scores 6 out of 10 in our fundamental rating. NHC was compared to 101 industry peers in the Health Care Providers & Services industry. While NHC has a great profitability rating, there are some minor concerns on its financial health. NHC has a valuation in line with the averages, but it does not seem to be growing. NHC also has an excellent dividend rating. With these ratings, NHC could be worth investigating further for dividend investing!.
1. Profitability
1.1 Basic Checks
In the past year NHC was profitable.
In the past year NHC had a positive cash flow from operations.
Each year in the past 5 years NHC has been profitable.
NHC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 6.71%, NHC belongs to the best of the industry, outperforming 85.15% of the companies in the same industry.
NHC has a better Return On Equity (10.26%) than 73.27% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.69%, NHC is in the better half of the industry, outperforming 66.34% of the companies in the same industry.
NHC had an Average Return On Invested Capital over the past 3 years of 3.68%. This is significantly below the industry average of 9.33%.
The 3 year average ROIC (3.68%) for NHC is below the current ROIC(6.69%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.71% | ||
| ROE | 10.26% | ||
| ROIC | 6.69% |
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
1.3 Margins
NHC's Profit Margin of 7.19% is amongst the best of the industry. NHC outperforms 86.14% of its industry peers.
In the last couple of years the Profit Margin of NHC has grown nicely.
NHC has a Operating Margin of 7.99%. This is in the better half of the industry: NHC outperforms 73.27% of its industry peers.
In the last couple of years the Operating Margin of NHC has grown nicely.
The Gross Margin of NHC (38.11%) is better than 66.34% of its industry peers.
NHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.99% | ||
| PM (TTM) | 7.19% | ||
| GM | 38.11% |
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NHC is destroying value.
Compared to 1 year ago, NHC has more shares outstanding
Compared to 5 years ago, NHC has more shares outstanding
The debt/assets ratio for NHC is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.13 indicates that NHC is not in any danger for bankruptcy at the moment.
The Altman-Z score of NHC (4.13) is better than 74.26% of its industry peers.
The Debt to FCF ratio of NHC is 0.93, which is an excellent value as it means it would take NHC, only 0.93 years of fcf income to pay off all of its debts.
NHC's Debt to FCF ratio of 0.93 is amongst the best of the industry. NHC outperforms 90.10% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that NHC is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.10, NHC is in the better half of the industry, outperforming 76.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.93 | ||
| Altman-Z | 4.13 |
ROIC/WACC0.79
WACC8.49%
2.3 Liquidity
A Current Ratio of 1.72 indicates that NHC should not have too much problems paying its short term obligations.
NHC has a Current ratio of 1.72. This is in the better half of the industry: NHC outperforms 62.38% of its industry peers.
A Quick Ratio of 1.69 indicates that NHC should not have too much problems paying its short term obligations.
The Quick ratio of NHC (1.69) is better than 63.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.72 | ||
| Quick Ratio | 1.69 |
3. Growth
3.1 Past
NHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.19%, which is quite good.
NHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.03% yearly.
Looking at the last year, NHC shows a very strong growth in Revenue. The Revenue has grown by 22.82%.
Measured over the past years, NHC shows a small growth in Revenue. The Revenue has been growing by 5.58% on average per year.
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 18.39, the valuation of NHC can be described as rather expensive.
76.24% of the companies in the same industry are more expensive than NHC, based on the Price/Earnings ratio.
NHC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.69.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.39 | ||
| Fwd PE | N/A |
4.2 Price Multiples
71.29% of the companies in the same industry are more expensive than NHC, based on the Enterprise Value to EBITDA ratio.
75.25% of the companies in the same industry are more expensive than NHC, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.09 | ||
| EV/EBITDA | 9.94 |
4.3 Compensation for Growth
The excellent profitability rating of NHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.29
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NHC has a Yearly Dividend Yield of 2.10%.
Compared to an average industry Dividend Yield of 2.45, NHC pays a better dividend. On top of this NHC pays more dividend than 93.07% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, NHC has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.1% |
5.2 History
The dividend of NHC has a limited annual growth rate of 3.30%.
NHC has paid a dividend for at least 10 years, which is a reliable track record.
NHC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.3%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
35.96% of the earnings are spent on dividend by NHC. This is a low number and sustainable payout ratio.
NHC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP35.96%
EPS Next 2YN/A
EPS Next 3YN/A
123.43
+1.48 (+1.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners59.33%
Inst Owner Change-0.11%
Ins Owners7.03%
Ins Owner Change1.07%
Market Cap1.91B
Analysts60
Price TargetN/A
Short Float %2.07%
Short Ratio4.19
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.1% |
Yearly Dividend2.4
Dividend Growth(5Y)3.3%
DP35.96%
Div Incr Years11
Div Non Decr Years11
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.39 | ||
| Fwd PE | N/A | ||
| P/S | 1.31 | ||
| P/FCF | 16.09 | ||
| P/OCF | 12.83 | ||
| P/B | 1.87 | ||
| P/tB | 2.3 | ||
| EV/EBITDA | 9.94 |
EPS(TTM)6.71
EY5.44%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)7.67
FCFY6.22%
OCF(TTM)9.62
OCFY7.79%
SpS94.07
BVpS65.93
TBVpS53.65
PEG (NY)N/A
PEG (5Y)2.29
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.71% | ||
| ROE | 10.26% | ||
| ROCE | 9.01% | ||
| ROIC | 6.69% | ||
| ROICexc | 8.35% | ||
| ROICexgc | 10.23% | ||
| OM | 7.99% | ||
| PM (TTM) | 7.19% | ||
| GM | 38.11% | ||
| FCFM | 8.16% |
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
ROICexc(3y)4.49%
ROICexc(5y)5.97%
ROICexgc(3y)5.54%
ROICexgc(5y)6.99%
ROCE(3y)4.96%
ROCE(5y)6.21%
ROICexcg growth 3Y-4%
ROICexcg growth 5Y11.11%
ROICexc growth 3Y-3.17%
ROICexc growth 5Y7.37%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
F-Score4
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.93 | ||
| Debt/EBITDA | 0.64 | ||
| Cap/Depr | 68.45% | ||
| Cap/Sales | 2.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 92.81% | ||
| Profit Quality | 113.47% | ||
| Current Ratio | 1.72 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 4.13 |
F-Score4
WACC8.49%
ROIC/WACC0.79
Cap/Depr(3y)68.9%
Cap/Depr(5y)71.13%
Cap/Sales(3y)2.45%
Cap/Sales(5y)2.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.08%
EBIT growth 3Y3.3%
EBIT growth 5Y11.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y219.85%
FCF growth 3Y51.34%
FCF growth 5Y1.58%
OCF growth 1Y136.11%
OCF growth 3Y19.81%
OCF growth 5Y1.4%